ΠΠΎΡΠ»Π΅Π΄Π½ΠΈΠ΅ Π΄ΠΎΠ±Π°Π²Π»Π΅Π½Π½ΡΠ΅ Π²ΠΈΠ΄Π΅ΠΎ:
ΡΠ΅ΡΠΈΡΠΈΠ½ΠΈΠ±
-
3 Π³ΠΎΠ΄Π° Π½Π°Π·Π°Π΄
567 3 Π³ΠΎΠ΄Π° Π½Π°Π·Π°Π΄ 18:04ΠΠ½ΡΠΈ-ALK ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ: ΠΡΠΈΠ·ΠΎΡΠΈΠ½ΠΈΠ± ΠΏΠΎΠΊΠΈΠ΄Π°Π΅Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΈ NCCN. ΠΠ»Π΅ΠΊΡΠΈΠ½ΠΈΠ± ΠΈ Π¦Π΅ΡΠΈΡΠΈΠ½ΠΈΠ±
-
10 Π»Π΅Ρ Π½Π°Π·Π°Π΄
727 10 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 1:18Ceritinib For Lung Cancer Treatment
-
8 Π»Π΅Ρ Π½Π°Π·Π°Π΄
669 8 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 6:12Experience with Ceritinib for ALK+ NSCLC
-
6 Π»Π΅Ρ Π½Π°Π·Π°Π΄
71 6 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 3:57ASCEND-8: safety data of ceritinib with or without food in NSCLC
-
5 Π»Π΅Ρ Π½Π°Π·Π°Π΄
251 5 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 1:48Dr. Chow on the Use of Ceritinib in ALK+ NSCLC Metastatic to the Brain
-
9 Π»Π΅Ρ Π½Π°Π·Π°Π΄
291 9 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 3:48Proactive management of ceritinib-related gastrointestinal reactions – Video abstract 96471
-
10 Π»Π΅Ρ Π½Π°Π·Π°Π΄
674 10 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 1:04Dr. Chu Discusses CNS Penetration of Ceritinib
-
8 Π»Π΅Ρ Π½Π°Π·Π°Π΄
163 8 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 5:15Results of ASCEND-4 trial of ceritinib versus chemotherapy in ALK+ NSCLC patients
-
8 Π»Π΅Ρ Π½Π°Π·Π°Π΄
559 8 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 5:21Ceritinib Alternative Dosing for ALK+ NSCLC
-
9 Π»Π΅Ρ Π½Π°Π·Π°Π΄
354 9 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 2:44Ceritinib and Brain Metastases in NSCLC
-
9 Π»Π΅Ρ Π½Π°Π·Π°Π΄
1584 9 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 7:21Ceritinib in Crizotinib-Resistant NSCLC
-
7 Π»Π΅Ρ Π½Π°Π·Π°Π΄
126 7 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 5:31FDA Approval: Frontline Ceritinib for ALK+ NSCLC
-
7 Π»Π΅Ρ Π½Π°Π·Π°Π΄
705 7 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 6:37ASCEND-4: Upfront Ceritinib in ALK-Rearranged NSCLC
-
8 Π»Π΅Ρ Π½Π°Π·Π°Π΄
87 8 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 1:23ASCEND-1 and ASCEND-2: Ceritinib for ALK-rearranged NSCLC and baseline brain metastases
-
8 Π»Π΅Ρ Π½Π°Π·Π°Π΄
1709 8 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 5:52Ceritinib and Alectinib in Relapsed ALK+ NSCLC
-
10 Π»Π΅Ρ Π½Π°Π·Π°Π΄
339 10 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 1:02Dr. Rolfo Discusses the Potential Utility of Ceritinib
-
7 Π»Π΅Ρ Π½Π°Π·Π°Π΄
204 7 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 6:47Upfront Use of Ceritinib in ALK+ NSCLC
-
8 Π»Π΅Ρ Π½Π°Π·Π°Π΄
243 8 Π»Π΅Ρ Π½Π°Π·Π°Π΄ 5:19ASCEND-5: Ceritinib for ALK positive NSCLC previously treated with crizotinib